Results 171 to 180 of about 68,977 (202)

Fibrinogenolysis in thrombotic thrombocytopenic purpura

American Journal of Hematology, 1989
AbstractCoagulo‐fibrinolytic factors were studied in five patients suffering from thrombotic thrombocytopenic purpura (TTP). The change in coagulation factors in the acute stage was mild compared with that found in disseminated intravascular coagulation (DIC).
E, Kakishita, T, Koyama, M, Higuchi, O, Kunitomi, Y, Oura, K, Nagai   +5 more
openaire   +2 more sources

Thrombotic thrombocytopenic purpura in childhood

Pediatric Blood & Cancer, 2009
AbstractThrombotic thrombocytopenic purpura (TTP) is a rare disease, especially in childhood, and has a high mortality rate in the absence of appropriate treatment. It is characterised by microangiopathic haemolytic anaemia and consumptive thrombocytopenia.
Maria C, Bouw, Natasja, Dors, Heleen, van Ommen, Nicole L, Ramakers-van Woerden   +3 more
openaire   +2 more sources

Thrombotic Thrombocytopenic Purpura and Vincristine

JAMA: The Journal of the American Medical Association, 1982
To the Editor.— We were interested in the recent article inThe Journal(1982;247:1433) by Lorence A. Gutterman, MD, and Thomas D. Stevenson, MD, which demonstrates that vincristine sulfate is capable of inducing remissions in patients with thrombotic thrombocytopenic purpura (TTP).
W J, Gundlach, R, Tarnasky
openaire   +2 more sources

Thrombotic Thrombocytopenic Purpura

Annual Review of Medicine, 1988
Platelet thrombus formation in small vessels is triggered by certain stimuli, including vascular injury, primary platelet agglutination, or both. The formation and dissolution of platelet thrombi is modulated by proteolysis, plasma factors, PGI2 synthesis and stability, and immune mechanisms.
openaire   +2 more sources

Thrombotic Thrombocytopenic Purpura: The Masquerader

Southern Medical Journal, 2009
Thrombotic thrombocytopenic purpura (TTP) is a life-threatening disorder with a mortality rate of up to 90% if left untreated, and is characterized by microvascular thrombi, mainly in small arteries and capillaries, thrombocytopenia, hemolysis, and neurological abnormalities.
Anil, Patel, Harsh, Patel, Anush, Patel
openaire   +2 more sources

Thrombotic thrombocytopenic purpura in siblings

The American Journal of Medicine, 1967
Abstract Reported herein are two cases of thrombotic thrombocytopenic purpura in sisters. In both the disease ran a chronic course terminating in the final episode of thrombotic thrombocytopenic purpura. Many of the clinical and pathologic findings resembled those in systemic lupus erythematosus.
S A, Norkin, H H, Freedman, G W, Evans
openaire   +2 more sources

Platelets: Thrombotic Thrombocytopenic Purpura

Hematology, 2002
Abstract Abnormalities of plasma von Willebrand factor (VWF) have been recognized to be associated with thrombotic thrombocytopenic purpura (TTP) for over 20 years. Patients with chronic, relapsing TTP have VWF multimers that are larger than normal, similar in size to those secreted by cultured endothelial cells. Recent observations have
James N, George, J Evan, Sadler, Bernhard, Lämmle   +2 more
openaire   +2 more sources

Thrombotic Thrombocytopenic Purpura-Then and Now

Seminars in Thrombosis and Hemostasis, 2006
Thrombotic thrombocytopenic purpura (TTP) is a potentially life-threatening disease characterized by microangiopathic hemolytic anemia, thrombocytopenia, and formation of microthrombi in several organs. The disease may manifest once in a lifetime or may relapse after complete recovery of the initial episode; in these recurrent cases, death or ...
Miriam, Galbusera, Marina, Noris, Giuseppe, Remuzzi   +2 more
openaire   +2 more sources

Thrombotic thrombocytopenic purpura

JAAPA, 2021
Zachary, Lavender, Lauren, Collin
openaire   +2 more sources

Evaluation and Management of Thrombotic Thrombocytopenic Purpura in the Emergency Department

Journal of Emergency Medicine, 2021
Michael Gottlieb, Brit Long, Rachel E Bridwell   +2 more
exaly